Publications: Determination of Cancer Aggressiveness

• San Antonio Breast Cancer Symposium 2025: Mitotic Circulating Tumor Cells Correlates with Poor Clinical Outcomes in Metastatic Breast Cancer Patients over a 3 Year Period

• AACR 2025: Heterogeneity of Epithelial, Mesenchymal, Progenitor, and Stem Cell Phenotypes on Circulating Tumor Cells Correlates to Clinical Outcomes in Metastatic Cancer Patients

• AACR 2025: Low CD47 Expression in Specific Populations of Tumor Macrophage Fusion Cells in Blood Correlates with Progressive Disease in Metastatic Cancers

• ASCO 2024: Polyploid Circulating Stromal Cells in Blood Identifies Invasive Solid Tumors and Prognosticates for Highly Aggressive Cancer Subtypes

• AACR 2024: Identifying and Stratifying Circulating Tumor Cell Cluster Subtypes in Metastatic Breast Cancer Patients and Evaluating their Clinical Outcomes

• AACR 2024: Monitoring prostate specific membrane antigen and androgen receptor expression on Circulating Stromal Cells in advanced prostate cancer patients and their correlation with patient response

• ASCO 2023:  Extracellular Vesicles Budding from Stromal Macrophages from the Blood Circulating in Metastatic Non-Small Cell Lung Cancer Patients Predict Clinical Outcome

• AACR 2023:  Micronuclei in circulating stromal cells correlates with PD-L1 expression and predicts progression in metastatic breast cancer

• AACR 2023: Tumor-macrophage fusion cells detected in the circulation of metastatic breast cancer patients is prognostic for rapid progression and death

• AACR 2023: Extracellular vesicles budding from stromal macrophages in the blood of metastatic non-small cell lung cancer patients correlates with poor survival

• ASCO 2021: Hyper-Engorged Cancer Associated Macrophage-Like Cells in Circulation Predict for Multi-Organ Metastatic Disease in Solid Tumors

• EDRN 2021: Enlarged Stromal Macrophages found in cancer patient blood are associated with more aggressive disease and poorer prognosis in localized stage I/II solid tumors

• AACR 2021: Cancer Associated Macrophage Like-Cells Predict Aggressive Disease in Local and Metastatic Prostate Cancers

• AACR 2021: CXCR4 expression in tumor associated circulating cells of patients with pancreatic cancer is prognostic for progression and overall survival

• AACR 2021: CCR5 upregulation in two subtypes of tumor associated circulating cells predict worse prognosis in metastatic breast cancer

• AACR 2020: Circulating Stromal Cells in Resectable Pancreatic Cancer is Associated with High Pathological Stage and Poor Clinical Outcomes

• ASCO 2019: Training and validation study for sequential monitoring of CAMLs in circulation to predict ongoing progression in lung cancer patients undergoing definitive radiotherapy

• AACR 2019: Combining circulating stromal cells with cell free DNA for increased sensitivity in profiling oncogenic mutations and indicates highly aggressive non-small cell lung cancer

• Tri-Con 2019: Cancer associated macrophage-like (CAMLs) cells in circulation predict progression and survival in all stages of solid tumors

• AACR 2018: Cancer associated macrophage-like (CAMLs) cells in blood predict progression and survival for all stages of solid tumors

• Tri-Con 2018: Cancer associated macrophage-like cells are prognostic indicators of survival in a variety of solid malignancies

• ISMRC 2016: Prognostic significance of mitosis in circulating tumor cells in breast cancer patients

• Tri-Con 2016: Mitosis in circulating tumor cells and its prognostic significance in late stage breast cancer

• ASCO 2015: Applying a mitotic index to circulating tumor cells and its prognostic significance: A cytological approach to patient stratification